Millipore Sigma Vibrant Logo

121767 AG 1024 - CAS 65678-07-1 - Calbiochem

121767
価格&在庫状況を照会

概要

Replacement Information

主要スペック表

Empirical FormulaCAS #
C₁₄H₁₃BrN₂O 65678-07-1

価格&在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
121767-1MGCN
在庫状況検索中…
現在国内在庫なし現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      樹脂アンプル 1 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示 
      値引
      ()
       
      弊社照会
      Description
      OverviewA cell-permeable, reversible, substrate competitive, and specific inhibitor of insulin-like growth factor-1 (IGF-1) and insulin receptor tyrosine kinase activity. Exhibits lower IC50 values for IGF-1 than for the insulin receptor. Also inhibits insulin-stimulated cellular proliferation.
      Catalogue Number121767
      Brand Family Calbiochem®
      Synonyms3-Bromo-5-t-butyl-4-hydroxy-benzylidenemalonitrile
      References
      ReferencesWen, B., et al. 2001. Br. J. Cancer 85, 2017.
      Parrizas, M., et al. 1997. Endocrinology 138, 1427.
      Ohmichi, M., et al. 1993. Biochemistry 32, 4650.
      Product Information
      CAS number65678-07-1
      ATP CompetitiveN
      FormOff-white to yellow solid
      Hill FormulaC₁₄H₁₃BrN₂O
      Chemical formulaC₁₄H₁₃BrN₂O
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetIGF-1
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze at -20°C. Stock solutions are stable for up to 2 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      AG 1024 - CAS 65678-07-1 - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート((M)SDS) 

      AG 1024 - CAS 65678-07-1 - Calbiochem 試験成績書(CoA)

      タイトルロット番号
      121767

      参考資料

      参考資料の概要
      Wen, B., et al. 2001. Br. J. Cancer 85, 2017.
      Parrizas, M., et al. 1997. Endocrinology 138, 1427.
      Ohmichi, M., et al. 1993. Biochemistry 32, 4650.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision05-April-2011 RFH
      Synonyms3-Bromo-5-t-butyl-4-hydroxy-benzylidenemalonitrile
      DescriptionA cell-permeable, reversible, substrate competitive, and specific inhibitor of insulin-like growth factor-1 (IGF-1) and insulin receptor kinases with significantly lower IC50 values for IGF-1 than for insulin receptors. Induces apoptosis by downregulating the expression of phospho-Akt1 and Bcl-2; and increasing the expression of Bax, p53 and p21. Reported to enhance the radiosensitivity of human breast cancer cells.
      FormOff-white to yellow solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number65678-07-1
      Chemical formulaC₁₄H₁₃BrN₂O
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (10 mg/ml)
      Storage -20°C
      Protect from light
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze at -20°C. Stock solutions are stable for up to 2 months at -20°C.
      Toxicity Standard Handling
      ReferencesWen, B., et al. 2001. Br. J. Cancer 85, 2017.
      Parrizas, M., et al. 1997. Endocrinology 138, 1427.
      Ohmichi, M., et al. 1993. Biochemistry 32, 4650.